Shrirang Karve - Concepedia

Author

Shrirang Karve

Translate Bio (United States)ORCID

Also Known As

Li, Chenxi, S Karve, S. Karve, S.S. Karve, Shrirang Karve, Wang, Edina C., Zhang, Liangfang

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Translate Bio (United States)Sanofi (United States)Sanofi (France)UNC Lineberger Comprehensive Cancer Center University of North Carolina at Chapel Hill

About

Shrirang Karve is an author at Translate Bio (United States) specializing in medicine, nanomedicine, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	730
2	Engineering	3	3	290
3	Biochemistry	2	2	54
4	Natural Sciences	1	1	20
5	Allergy	1	1	20

Shrirang Karve

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis Michael E. Werner, Shrirang Karve, Rohit Sukumar, Biomaterials NanomedicineNanotherapeuticsTherapeutic NanomaterialsMedicineFolate-targeted Nanoparticle Delivery	2011	167
Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system Frank DeRosa, Braydon C. Guild, Shrirang Karve, Gene Therapy	2016	155
Revival of the abandoned therapeutic wortmannin by nanoparticle drug delivery Shrirang Karve, Michael E. Werner, Rohit Sukumar, Proceedings of the National Academy of Sciences NanoparticlesEngineeringNp WtmnBiomedical EngineeringTumor Biology	2012	146
Folate-Targeted Polymeric Nanoparticle Formulation of Docetaxel Is an Effective Molecularly Targeted Radiosensitizer with Efficacy Dependent on the Timing of Radiotherapy Michael E. Werner, Jonathan A. Copp, Shrirang Karve, ACS Nano NanoparticlesNanotherapeuticsEngineeringDocetaxel IsFt-np Dtxl	2011	119
Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza Sudha Chivukula, Timothy Plitnik, Timothy Tibbitts, npj Vaccines VaccinationVaccine ModalityCross-protectionVaccine DevelopmentPandemic Influenza	2021	110
Effect of drug release kinetics on nanoparticle therapeutic efficacy and toxicity Manish Sethi, Rohit Sukumar, Shrirang Karve, Nanoscale	2014	89
Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models Kirill V. Kalnin, Timothy Plitnik, Michael Kishko, npj Vaccines	2021	82
The pH-dependent association with cancer cells of tunable functionalized lipid vesicles with encapsulated doxorubicin for high cell-kill selectivity Shrirang Karve, Amey Bandekar, Md. Ramjan Ali, Biomaterials NanomedicinePh-dependent AssociationNanotherapeuticsPolymer-drug ConjugateMedicine	2010	47
Inhalable dry powder product (DPP) of mRNA lipid nanoparticles (LNPs) for pulmonary delivery Ashish Sarode, Priyal Patel, Natalia Vargas‐Montoya, Drug Delivery and Translational Research	2023	44
Antitumor efficacy following the intracellular and interstitial release of liposomal doxorubicin Amey Bandekar, Shrirang Karve, Min-Yuan Chang, Biomaterials Interstitial ReleaseOncologyMedicineAntitumor EfficacyLiposomal Doxorubicin	2012	42

Page 1